midazolam and vx680
midazolam has been researched along with vx680 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Abécassis, PY; Angouillant-Boniface, O; Bertrand, T; Bjergarde, K; Carry, JC; Clerc, F; Combeau, C; Crocq-Stuerga, V; Delarbre, L; Delorme, C; Doerflinger, G; Filoche-Rommé, B; Gasse, F; Gontier, S; Guizani, H; Krick, A; Lachaud, S; Le Moigne, R; Lebel, R; Ma, N; Maignan, S; Mauger, J; Minoux, H; Monget, S; Monteiro, ML; Murer, M; Nair, A; Nicolas, JP; Parmantier, E; Perron, S; Pouzieux, S; Prévost, C; Schio, L | 1 |
Other Studies
1 other study(ies) available for midazolam and vx680
| Article | Year |
|---|---|
SAR156497, an exquisitely selective inhibitor of aurora kinases.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Benzimidazoles; Female; HCT116 Cells; Humans; Mice, SCID; Models, Chemical; Models, Molecular; Molecular Structure; Neoplasms; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quinolones; Sf9 Cells; Small Molecule Libraries; Xenograft Model Antitumor Assays | 2015 |